Zomedica Corp (NYSEAMERICAN:ZOM) stock continues to see heavy selling pressure and today slipped to a 4-month low as the stock has lost over 75% from its 52-week high of $2.91.
Late Wednesday, the company reported a loss of $4.0 million or 4 cents a share, compared to a loss of $2.5 million, or 2 cents a share in the same quarter of the last year.
Revenue for the three months ended March 31, 2021 was $14,124 and resulted from the sale of our TRUFORMA® products and associated warranties.
Zomedica had cash and cash equivalents of approximately $276.6 million as of March 31, 2021, compared to approximately $1.5 million as of March 31, 2020.
Despite the recent slump, ZOM stock is still up 200% so far this year and 1115% from its 52-week low of $0.063.
Editor in Chief.
Living in the era of dynamic tech change Alex decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring in Finance) writing for technology and as well as finance has been one of the precious aspects of his life